Z-0756-2013 Class II Terminated
FDA device recall Z-0756-2013 was initiated by Becton Dickinson & Company on Nov 12, 2012 and is designated Class II. Reason for recall: BD is conducting a recall of the BD Vacutainer 2.7mL Plus Citrate Blood Collection Tube due to extended Partial Thromboplastin Time (aPTT) test results reported in two customer complaints. The recall status is terminated (terminated Sep 6, 2013). Affected quantity: 2,944,700 units.
Recall details
- Product Type
- Devices
- Report Date
- Feb 6, 2013
- Initiation Date
- Nov 12, 2012
- Termination Date
- Sep 6, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,944,700 units
Product description
BD Vacutainer Buffered Sodium Citrate (9NC) Plus Blood Collection Tubes; Sterile; IVD; REF 363083; 13 X 75 mm, 2.7 mL
Reason for recall
BD is conducting a recall of the BD Vacutainer 2.7mL Plus Citrate Blood Collection Tube due to extended Partial Thromboplastin Time (aPTT) test results reported in two customer complaints.
Distribution pattern
Worldwide Distribution-USA (nationwide) and the countries of Canada, India, Japan, Nepal, Malaysia, Singapore, Brazil, Costa Rica, and Virgin Islands.
Code information
Lot No. 2180434; Expiration Date: April 2013
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0756-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026